Commerce Dashboard

Sanofi India Ltd.

Go Back

Sanofi India Ltd.

  • Around 3,500 employees in India.
  • Operates in India through five entities.
  • As of December 2014, total assets stood at Rs 1,485.84 crore (US$ 237.32 million).

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme.

In India, Sanofi operates through five entities - Sanofi India Ltd (previously known as Aventis Pharma Ltd), Sanofi-Synthelabo (India) Ltd, Sanofi Pasteur India Private Ltd, Shantha Biotechnics Ltd and Genzyme India Private Ltd.


Sanofi India: Committed to India’s health since 1956

2009 Shantha Biotechnics Ltd (Shantha) has become a part of the Sanofi group.
2002 The name was changed to Sanofi-Synthelabo (India) Ltd.
1996 Sanofi-Synthelabo (India) Ltd was incorporated in June 1996 under the name Sanofi Torrent (India) Private Ltd.
1956 Sanofi India Ltd was incorporated under the name Hoechst Fedco Pharma Private Ltd.
India ranks 3rd worldwide for pharmaceutical production by volume and 14th by value. The country has an established domestic pharmaceutical industry, with a strong network of 3,000 drug companies and ~10,500 manufacturing units.